Acadia Pharmaceuticals Inc. · NASDAQ:ACAD

Kihara James sold 1,030 Acadia Pharmaceuticals Inc. shares (Form 4)

Traded Apr 5 to Apr 7, 2026 · Filed Apr 7, 2026

From Apr 5 to Apr 7, 2026, Kihara James (PRINCIPAL ACCOUNTING OFFICER) sold 1,030 Acadia Pharmaceuticals Inc. shares at US$22.20 for US$22,866, leaving 27,865 shares. Filed Apr 7, 2026 (Form 4).

Sold
1,030 shares
Price
US$22.20
Value
US$22,866
Holding after
27,865 shares
Trading plan
No
Role
PRINCIPAL ACCOUNTING OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 5, 2026Common StockOption exercise2,01028,895Direct
Apr 7, 2026Common StockSale1,030US$22.2027,865Direct

Source

View original at SEC

Related